RT3
Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity?
Sheila A Doggrell · 2023
Research
Expert Opinion on Investigational Drugs
Approved and reviewable research records from Expert Opinion on Investigational Drugs.